Pugh, S. L., Lee, W. R., Dignam, J., Low, D., Swanson, G. P., Shah, A. B., … Bruner, D. W. (2017). NRG Oncology/RTOG 0415, hypofractionation in patients with low-risk prostate cancer: are patient reported outcomes the practice change tipping point? In QUALITY OF LIFE RESEARCH (Vol. 26, pp. 38–39). SPRINGER.

Pugh, Stephanie L., W. R. Lee, James Dignam, Daniel Low, Gregory P. Swanson, Amit B. Shah, David P. D’Souza, et al. “NRG Oncology/RTOG 0415, hypofractionation in patients with low-risk prostate cancer: are patient reported outcomes the practice change tipping point?” In QUALITY OF LIFE RESEARCH, 26:38–39. SPRINGER, 2017.

Pugh SL, Lee WR, Dignam J, Low D, Swanson GP, Shah AB, et al. NRG Oncology/RTOG 0415, hypofractionation in patients with low-risk prostate cancer: are patient reported outcomes the practice change tipping point? In: QUALITY OF LIFE RESEARCH. SPRINGER; 2017. p. 38–9.

Pugh, Stephanie L., et al. “NRG Oncology/RTOG 0415, hypofractionation in patients with low-risk prostate cancer: are patient reported outcomes the practice change tipping point?” QUALITY OF LIFE RESEARCH, vol. 26, no. 1, SPRINGER, 2017, pp. 38–39.

Pugh SL, Lee WR, Dignam J, Low D, Swanson GP, Shah AB, D’Souza DP, Michalski JM, Dayes IS, Seaward SA, Nguyen PL, Hall WA, Pisansky TM, Chen Y, Sandler HM, Movsas B, Bruner DW. NRG Oncology/RTOG 0415, hypofractionation in patients with low-risk prostate cancer: are patient reported outcomes the practice change tipping point? QUALITY OF LIFE RESEARCH. SPRINGER; 2017. p. 38–39.